Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Our lead product is Eroxon®a clinically proven breakthrough treatment for erectile dysfunction
Products FAQs
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
WEBCASTS
Videos and webcasts
Shareholder centre
This section contains the latest RNS, news and videos.
Total Voting Rights
Directors’ / PDMR Dealing
Trinity Delta research note & consensus forecasts
Read more
33.75p (GB)
Change: -0.35 Last updated: 22:08
Share price information delayed at least 15 minutes
Download our Interim Results 2024
10 September 2024
10 April 2024
©2024 Futura Medical